Ally Bridge Group’s Gossamer Bio GOSS Stock Holding History

Ally Bridge Group’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-377,000	Closed	-$4.52M	–	35
2022 Q3	$4.52M	Sell	377,000 -323,000	-46%	-$4.01M	2.98%	14
2022 Q2	$5.86M	Buy	700,000 +250,000	+56%	+$1.94M	5.34%	7
2022 Q1	$3.91M	Sell	450,000 -25,000	-5%	-$241K	2.9%	16
2021 Q4	$5.37M	Sell	475,000 -700,000	-60%	-$8.31M	1.88%	23
2021 Q3	$14.8M	Hold	1,175,000	–	–	4.34%	10
2021 Q2	$9.54M	Buy	+1,175,000	New	+$10.2M	2.37%	22

Other funds holding GOSS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ally Bridge Group's GOSS Position: Q4 2022 in Review

Ally Bridge Group sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 377,000 shares — an estimated $4.52M sold.

Ally Bridge Group first reported a position in GOSS in Q2 2021 and held it in 6 quarters. The position peaked at $14.8M in Q3 2021. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

Ally Bridge Group reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
Ally Bridge Group sold 377,000 Gossamer Bio shares in Q4 2022, an estimated $4.52M.
Ally Bridge Group first reported a position in Gossamer Bio in Q2 2021 and held it in 6 quarters.
Ally Bridge Group's Gossamer Bio position peaked at $14.8M in Q3 2021.
120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Ally Bridge Group's 13F filing for Q4 2022, filed 14 Feb 2023.